Reports: Interim report Q1 2023

Press release from Companies: Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer

Press release from Companies: Resolutions of the Annual General Meeting of Curasight A/S

Press release from Companies: Notice of Annual General Meeting 2023

Press release from Companies: Annual Report for the fiscal year 2022

Reports: Year-end report October - December 2022

Press release from Companies: Curasight to present at HC Andersen Capital

Press release from Companies: Curasight to present at Redeye Fight Cancer Seminar

Reports: Interim Report January – September 2022

Press release from Companies: Curasight to present at HC Andersen Capital

Press release from Companies: Curasight to present at SEB Healthcare Seminar 2022

Press release from Companies: Curasight initiates pre-clinical studies with uTREAT[®] therapy in head and neck cancer (HNSCC) and neuroendocrine tumors (NET)